\begin{thebibliography}{10}

\bibitem{nchs}
Jiaquan~Xu et~al.
\newblock Mortality in the {United States}.
\newblock {\em NCHS Data Brief}, 2021.

\bibitem{EvasionMech}
Kim S.Ka. and Cho S.W.
\newblock The evasion mechanisms of cancer immunity and drug intervention in
  the tumor microenvironment.
\newblock {\em Front Pharmacol.}, 13(868695), 2022.

\bibitem{ReviewCPI}
Alex~D. Waldman, Jill~M. Fritz, and Michael~J. Lenardo.
\newblock A guide to cancer immunotherapy: from t cell basic science to
  clinical practice.
\newblock {\em Nature Reviews}, 20:651--69, 2020.

\bibitem{cd8Effects}
B.V. Kumar, T.J. Connors, and D.L. Farber.
\newblock Human t cell development, localization, and function throughout life.
\newblock {\em Immunity}, 48:202--213, 2018.

\bibitem{ioDef}
I.L.~Jr Bennet and P.B. Beeson.
\newblock Studies on the pathogenesis of fever - characterization of
  fever-producing substances from polymorphonuclear leukocytes and from the
  fluid of sterile exudates.
\newblock {\em J Exp Med.}, 98:493--508, 1953.

\bibitem{il12IsCool}
R.~Mortarini, A.~Borri, G.~Targni, et~al.
\newblock Peripheral burst of tumor-specific cytotoxic t lymphocytes and
  infiltration of metastatic lesions by memory cd8+ t cells in melanoma
  patients receiving interleukin 12.
\newblock {\em Cancer Res.}, 60:3559--68, 2000.

\bibitem{cd8FirstWay}
A.~Mukhopadhyay, J.~Wright, S.~Shirley, D.A. Canton, C.~Burkart, R.J. Connolly,
  et~al.
\newblock Characterization of abscopal effects of intratumoral
  electroporation-mediated {IL-12} gene therapy.
\newblock {\em Gene Ther.}, 26:1--15, 2019.

\bibitem{il12CytokineStorm}
J.E. Portielje, C.H. Lamers, W.H. Kruit, A.~Sparreboom, R.L. Bolhuis,
  G.~Stoter, et~al.
\newblock Repeated administrations of interleukin {(IL)-12} are associated with
  persistently elevated plasma levels of {IL-10} and declining {IFN-gamma},
  tumor necrosis factor-alpha, {IL-6}, and {IL-8} responses.
\newblock {\em Clin Cancer Res}, 9, 76-83.

\bibitem{ifngAngiogenesis}
Y.~Hayakawa, K.~Takeda, H.~Yagita, M.J. Smyth, L.~Van~Kaern, K.~Okumura, et~al.
\newblock Ifn-gamma-mediated inhibition of tumor angiogenesis by natural killer
  t-cell ligand, alpha-galactosylceramide.
\newblock {\em Blood}, 100, 2002.

\bibitem{ifngNKProd}
L.K. Chen, B.~Tourvieille, G.F. Burns, F.H. Bach, D.~Mathieu-Mahul,
  M.~Sasportes, and other.
\newblock Interferon: a cytotoxic {T lymphocyte} differentiation signal.
\newblock {\em Eur J Immunol}, 17, 767-70.

\bibitem{ifngAntigenExposure}
F.M. Rosa, M.M. Cochet, and M.~Fellous.
\newblock Interferon and major histocompatibility complex genes: a model to
  analyse eukaryotic gene regulation?
\newblock {\em Interferon}, 7:47--87, 1986.

\bibitem{reducImmunoSuppression}
S.A. Rosenberg, B.S. Packard, P.M. Aebersold, D.~Solomon, S.L. Topalian, S.T.
  Toy, et~al.
\newblock Use of tumor-infiltrating lymphocytes and interleukin-2 in the
  immunotherapy of patients with metastatic melanoma.
\newblock {\em N Engl J Med}, 319:1676--80, 1988.

\bibitem{cpiProof}
B.T. Fife and J.~A Bluestone.
\newblock Control of peripheral t-cell tolerance and autoimmunity via the
  ctla-4 and pd-1 pathways.
\newblock {\em Immunol. Rev}, 224:166--182, 2008.

\bibitem{PD1Autoimmune}
H.~Nishimura, N.~Minato, T.~Nakano, and T.~Honjo.
\newblock Immunological studies on {PD-1} deficient mice: implication of {PD-1}
  as a negative regulator for {B} cell responses.
\newblock {\em Int Immunol}, 10:1563--72, 1998.

\bibitem{PDvsCTLA}
B.T. Fife and J.A. Bluesone.
\newblock Control of peripheral {T-cell} tolerance and autoimmunity via the
  {CTLA-4} and {PD-1} pathways.
\newblock {\em Immunol. Rev.}, 224, 166-182.

\bibitem{cbdil12}
A.~Mansurov, J.~Ishihara, P.~Hosseinchi, et~al.
\newblock Collagen-binding il-12 enhances tumour inflammation and drives the
  complete remission of established immunologically cold mouse tumours.
\newblock {\em Nature Biomedical Engineering}, 4:531--543, 2020.

\bibitem{takuya}
Takuya Miyano.
\newblock Mathematical modeling of complete remission of immunologically cold
  tumor by tumor-matrix targeted interleukin-12, 2019.

\bibitem{christian1}
Christian Hines.
\newblock Cancer immunotherapy meeting notes, 2022.

\bibitem{christian2}
Christian Hines.
\newblock Positive feedback between {IL-12} and {IFN}g, 2022.

\bibitem{rosenbaum}
B.~Rosenbaum, M.~Raats, et~al.
\newblock Estimating parameters from multipple time series of population
  dynamics using bayesian inference.
\newblock {\em Frontiers in Ecology and Evolution}, 6(234), 2019.

\bibitem{sens_review}
Bertrand Iooss and Paul Lema√Ætre.
\newblock A review on global sensitivity analysis methods.
\newblock {\em Uncertainty management in {Simulation-Optimisation of Complex
  Systems: Algorithms and Applications}}, Springer, 2015.

\bibitem{gelman2020bayesian}
Andrew Gelman et~al.
\newblock {Bayesian Workflow}, 2020.

\bibitem{ABCtuber}
Tanaka M.M. et~al.
\newblock Using approximate bayesian computation to estimate tuberculosis
  transmission parameters from genotype data.
\newblock {\em Genetics}, 173(3):1511--1520, 2006.

\bibitem{ABCerror}
Christian~P. Robert, Jean-Marie Cornuet, Jean-Michel Marin, and Natesh~S.
  Pillai.
\newblock Lack of confidence in approximate bayesian computation model choice.
\newblock {\em Proceedings of the National Academy of Sciences},
  108(37):15112--15117, 2011.

\end{thebibliography}
